Iconovo welcomes Dr. Agneta Walhagen as new member of the Board of Directors at Iconovo.
Agneta has over 26 years of experience working within research and development in the pharmaceutical industry in both preclinical, clinical and commercial development. She has 20 years of inhalation experience from AstraZeneca where she had several senior leadership positions, both as manager/director, project leader and portfolio manager. She is currently working at LEO Pharma as Senior Director of R&D Alliance Management. She was previously heading Pharmaceutical Technologies and early Business Development at LEO Pharma.
”We are very pleased to have Agneta on our board. She brings a fantastic experience from the pharma industry and scientific expertise in the inhalation field” says Iconovo’s CEO, Orest Lastow.